OpenAI is collaborating with a longevity startup to explore innovative approaches to extending human life. This partnership aims to leverage advanced artificial intelligence and biotechnology to identify and develop potential therapies that could slow aging and enhance healthspan. The initiative reflects a growing interest in the intersection of AI and healthcare, as researchers seek to harness machine learning to analyze vast datasets related to aging and disease.
Editor’s Note: Those medical and genetic data that many readily gave up during the COVID era has now found its purpose. Did you think OpenAI only wanted to help you write your papers better? [Also read ChatGPT-Like AI Designs Whole New Genomes From Scratch, This Ambitious Project Wants to Sequence the DNA of All Complex Life on Earth].
Read Original Article
Read Online
Click the button below if you wish to read the article on the website where it was originally published.
Read Offline
Click the button below if you wish to read the article offline.